Standout Papers

Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic ... 2007 2026 2013 2019 1.1k
  1. Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria (2007)
    Haesun Choi, C Charnsangavej et al. Journal of Clinical Oncology
  2. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial (2009)
    Ronald P. DeMatteo, Karla V. Ballman et al. The Lancet
  3. Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial (2015)
    George D. Demetri, Margaret von Mehren et al. Journal of Clinical Oncology
  4. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial (2016)
    Patrick Schöffski, Sant P. Chawla et al. The Lancet
  5. Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 (2007)
    Robert G. Maki, J. Kyle Wathen et al. Journal of Clinical Oncology
  6. Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy (2003)
    Gunar K. Zagars, Matthew T. Ballo et al. Cancer
  7. We Should Desist Using RECIST, at Least in GIST (2007)
    Robert S. Benjamin, Haesun Choi et al. Journal of Clinical Oncology

Immediate Impact

4 by Nobel laureates 24 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Ewing’s Sarcoma
2021 Standout
Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
16 intermediate papers

Works of Shreyaskumar Patel being referenced

Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients
2017
Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial
2014
and 10 more

Author Peers

Author Last Decade Papers Cites
Shreyaskumar Patel 10447 5750 2571 3372 256 14.2k
Axel Le Cesne 9466 6995 2543 2146 264 14.2k
Angelo Paolo Dei Tos 10249 5978 2332 2968 432 16.0k
Peter Hohenberger 8759 4938 1912 3646 363 13.4k
Axel Le Cesne 7244 4194 1822 1639 267 9.8k
Sylvie Bonvalot 8578 5064 2621 2683 262 11.3k
Alessandro Gronchi 14831 7172 4429 2971 463 18.3k
Jean‐Michel Coindre 12105 7369 3970 1811 293 17.3k
Steven I. Hajdu 6513 4298 1747 3324 228 11.1k
Chandrajit P. Raut 5882 4167 1641 3196 199 9.2k
Paolo G. Casali 18356 8147 4046 5257 424 24.0k

All Works

Loading papers...

Rankless by CCL
2026